Financial Statements Group Subsidiaries and Holdings In accordance with Section 409 of the Companies Act 2006 a full list of subsidiaries, partnerships, associates and joint ventures, the country of incorporation and the effective percentage of equity owned as at 31December 2015 are disclosed below.
Unless otherwise stated the share capital disclosed comprises ordinary shares which are indirectly held by AstraZeneca PLC.
Unless otherwise stated the accounting year ends of subsidiaries are 31 December.
Products are manufactured in 17 countries worldwide and are sold in over 100 countries.
The Group Financial Statements consolidate the Financial Statements of the Company and its subsidiaries at 31December 2015.
Percentage of Percentage of voting share voting share At 31 December 2015 Country capital held At 31 December 2015 Country capital held Wholly owned subsidiaries AstraZeneca GmbH Germany 100 Aktiebolaget Hssle Sweden 100 AstraZeneca Health Care S. A. fide C. V. Mexico 100 4 AlphaCore Pharma Limited England 100 AstraZeneca Holding Aktiebolag Sweden 100 1 AlphaCore Pharma, LLC United States 100 AstraZeneca Holding France S. A. S. France 100 1 Amylin Ohio LLC United States 100 AstraZeneca Holding GmbH Germany 100 1 Amylin Pharmaceuticals LLC United States 100 AstraZeneca Holdings B. V. Netherlands 100 Ardea Biosciences Limited England 100 AstraZeneca Holdings Pty Limited Australia 100 Ardea Biosciences, Inc. United States 100 AstraZeneca Hong Kong Limited Hong Kong 100 Arrow Therapeutics Limited England 100 AstraZeneca Ilac Sanayi five Ticaret Limited Sirketi Turkey 100 5 Astra Alpha Produtos Farmaceuticos Lda Portugal 100 AstraZeneca India Private Limited India 100 Astra Export & Trading Aktiebolag Sweden 100 AstraZeneca Industries, LLC Russia 100 Astra Lkemedel Aktiebolag Sweden 100 AstraZeneca Insurance Company Limited England 100 4 Astra Pharmaceuticals Pty Limited South Africa 100 AstraZeneca Intermediate Holdings Limited England 100 2 Astra Pharmaceuticals Limited England 100 AstraZeneca International Holdings Aktiebolag Sweden 100 Astra Tech International Aktiebolag Sweden 100 AstraZeneca Investment China Co. Ltd China 100 2 AstraPharm England 100 AstraZeneca Investments Limited England 100 AstraZeneca A S Denmark 100 AstraZeneca Israel Ltd Israel 100 AstraZeneca do Brasil Limitada Brazil 100 AstraZeneca Japan Limited England 100 AstraZeneca Thailand Limited Thailand 100 AstraZeneca Jota B. V. Netherlands 100 AstraZeneca Wuxi Trading Co. Ltd China 100 AstraZeneca K. K. Japan 100 AstraZeneca AB Sweden 100 AstraZeneca Kft Hungary 100 AstraZeneca AG Switzerland 100 AstraZeneca Korea Co. Ltd Republic of Korea 100 AstraZeneca AS Norway 100 AstraZeneca Latvija SIA Latvia 100 AstraZeneca Lietuva UAB Lithuania 100 AstraZeneca Asia-Pacific Business ServicesSDN BHD Malaysia 100 AstraZeneca Limited New Zealand 100 AstraZeneca B. V. Netherlands 100 AstraZeneca Luxembourg S. A. Luxembourg 100 AstraZeneca Biotech AB Sweden 100 AstraZeneca Maroc SARLAU Morocco 100 AstraZeneca BioVentureHub AB Sweden 100 AstraZeneca Nigeria Limited Nigeria 100 AstraZeneca Bulgaria EOOD Bulgaria 100 AstraZeneca Nominees Limited England 100 AstraZeneca CAMCAR Costa Rica, S. A. Costa Rica 100 AstraZeneca Nordic AB Sweden 100 AstraZeneca CAMCAR, S. A. Panama 100 AstraZeneca sterreich GmbH Austria 100 3 AstraZeneca Canada Inc. Canada 100 AstraZeneca OY.
Finland 100 AstraZeneca China UK Limited England 100 AstraZeneca Peru S. A. Peru 100 1 AstraZeneca Collaboration Ventures LLC United States 100 AstraZeneca Pharma Poland Sp.
z. o. o. Poland 100 AstraZeneca Colombia S. A. Colombia 100 AstraZeneca Pharma S. R. L. Romania 100 AstraZeneca Continent B. V. Netherlands 100 AstraZeneca Pharmaceutical China Co. Ltd China 100 AstraZeneca Czech Republic, s. r. o. Czech Republic 100 AstraZeneca Pharmaceuticals Phils.
Inc. Philippines 100 AstraZeneca d. o. o. Croatia 100 AstraZeneca Pharmaceuticals Pty Limited South Africa 100 AstraZeneca Death In Service Trustee Limited England 100 AstraZeneca Pharmaceuticals Aktiebolag Sweden 100 AstraZeneca Dunkerque Production SCS France 100 AstraZeneca Pharmaceuticals Co. Limited.
China 100 AstraZeneca Eesti O Estonia 100 AstraZeneca Pharmaceuticals Ireland Limited Ireland 100 AstraZeneca Egypt for AstraZeneca Pharmaceuticals Limited Kenya 100 Pharmaceutical Industries JSC Egypt 100 AstraZeneca Pharmaceuticals, LLC Russia 100 AstraZeneca Egypt for Trading LLC Egypt 100 AstraZeneca Pharmaceuticals AstraZeneca Employee Share Trust Limited England 100 Pakistan Private Limited Pakistan 100 6 AstraZeneca Farmaceutica Chile Limitada Chile 100 AstraZeneca Pharmaceuticals, LP United States 100 AstraZeneca Farmaceutica Holding Spain, S. A. Spain 100 AstraZeneca Produtos Farmaceuticos Lda Portugal 100 AstraZeneca Farmaceutica Spain S. A. Spain 100 AstraZeneca PTY Limited Australia 100 AstraZeneca Finance Coperatief WA Netherlands 100 AstraZeneca Quest Limited England 100 AstraZeneca Finance Limited England 100 AstraZeneca Reims S. A. S. France 100 AstraZeneca Finance S. A. S. France 100 AstraZeneca Rho B. V. Netherlands 100 AstraZeneca FZ-LLC United Arab Emirates 100 AstraZeneca S. A. Greece 100 AstraZeneca Gamma B. V. Netherlands 100 AstraZeneca S. A. Chile 100 194 AstraZeneca Annual Report and Form 20-F Information 2015 Financial Statements Percentage of Percentage of voting share voting share At 31 December 2015 Country capital held At 31 December 2015 Country capital held AstraZeneca S. A. Argentina 100 Pharmaceutical Manufacturing CompanyPtyLimited Australia 100 AstraZeneca S. A. N. V. Belgium 100 AstraZeneca S. A. S. France 100 Pharmaceutical Manufacturing 3 DivisionPtyLimited Australia 100 AstraZeneca S. A. Uruguay 100 Simesa SpA Italy 100 AstraZeneca Sdn Bhd Malaysia 100 Sofotec GmbH Germany 100 AstraZeneca Share Trust Limited England 100 2 Spirogen Sarl Switzerland 100 AstraZeneca Sigma B. V. Netherlands 100 1 Stauffer Management Company LLC United States 100 AstraZeneca Singapore Pte Limited Singapore 100 Stuart-Produtos Farmacuticos Lda Portugal 100 AstraZeneca Sdertalje 1 AB Sweden 100 Stuart Pharma Aktiebolag Sweden 100 AstraZeneca Sdertalje 2 AB Sweden 100 2 Symbicom Aktiebolag Sweden 100 AstraZeneca SpA Italy 100 Tika Lkemedel Aktiebolag Sweden 100 AstraZeneca Sweden Investments Limited England 100 3 Zenco No 8 Limited England 100 AstraZeneca Taiwan Limited Taiwan 100 2 Zeneca Epsilon Produtos Farmacuticos Lda Portugal 100 AstraZeneca Treasury Limited England 100 Zeneca Finance Netherlands Company England 100 AstraZeneca Tunisie SaRL Tunisia 100 Zeneca Holdings Inc. United States 100 AstraZeneca UK Limited England 100 Zeneca Ilac Sanayi five Ticaret Anonim Sirketi Turkey 100 AstraZeneca Ukraina LLC Ukraine 100 4 Zeneca Inc. United States 100 AstraZeneca US Investments Limited England 100 4 Zeneca Wilmington Inc. United States 100 Bolivarian Republic Zenecapharma Produtos Farmaceuticos Lda Portugal 100 AstraZeneca Venezuela S. A. ofVenezuela 100 ZS Pharma Inc. United States 100 AstraZeneca Zeta B. V. Netherlands 100 6 Subsidiaries where the effective interest is less than 100% AstraZeneca, LP United States 100 5 AstraZeneca Pharma India Limited India 75 AstraZeneca, S. A. fide C. V. Mexico 100 I. C. Insurance Holdings Limited England 51 Atkemix Nine Inc. United States 100 P. T. AstraZeneca Indonesia Indonesia 95 Atkemix Ten Inc. United States 100 8 SPA AstraZeneca Al Djazair Algeria 65.77 Ayzee 1 Limited England 100 Joint ventures AYZEE 2 Limited England 100 8 Archigen Biotech Limited England 50 AYZEE 3 Limited England 100 8 Centus Biotherapeutics Limited England 50 AYZEE 4 Limited England 100 Montrose Chemical Corporation of California United States 50 AZ Reinsurance Limited Cayman Islands 100 Significant holdings AZENCO2 Limited England 100 9 1 Albireo Limited England 23.5 AZLP Holdings LLC United States 100 C. C. Global Chemicals Company United States 37.5 AZ-Mont Insurance Company United States 100 Other holdings BMS Holdco Inc. United States 100 10 ADC Therapeutics Srl Switzerland 8.84 Cambridge Antibody Technology Group Limited England 100 Adherium Limited New Zealand 5.6 Corpus Christi Holdings Inc. United States 100 11 Affinita Biotech, Inc. United States 16.22 Cresco Ti Systems GmbH Germany 100 12 Armaron Bio Pty Ltd Australia 17.43 Definiens AG Germany 100 12 BlinkBio Inc. United States 18.49 Definiens Inc. United States 100 Catabasis Pharmaceuticals, Inc. United States 10.7 Drimex LLC Egypt 100 13 Cerapedics, Inc. United States 8.61 Entasis Therapeutics Inc. United States 100 14 7 Elusys Therapeutics, Inc. United States 7.2 Entasis Therapeutics Limited England 100 Fibrogen, Inc. United States 1.8 Bolivarian Republic 15 Gotland Pharma S. A. ofVenezuela 100 G1 Therapeutics, Inc. United States 18.03 IPR Pharmaceuticals, Inc. Puerto Rico 100 Hydra Biosciences Inc. United States 4.27 KuDOS Horsham Limited England 100 Inotek Pharmaceuticals Corporation United States 7.3 16 KuDOS Pharmaceuticals Limited England 100 Moderna Therapeutics Inc. United States 7 13 Laboratorio Beta, S. A. Spain 100 PhaseBio Pharmaceuticals, Inc. United States 14.5 Laboratorio Icaro S. A. Spain 100 Regulus Therapeutics Inc. United States 6.7 Laboratorio Lailan, S. A. Spain 100 Silence Therapeutics PLC England 0.17 17 Laboratorio Odin, S. A. Spain 100 VentiRx Pharmaceuticals, Inc. United States 12 Laboratorio Tau S. A. Spain 100 1 Ownership held as membership interest.
2 MedImmune Biologics Inc. United States 100 Ownership held in class A and B shares.
3 Ownership held in ordinary and special shares.
MedImmune Limited England 100 4 Directly held by AstraZeneca PLC.
5 Accounting year end is 31 March.
MedImmune Pharma B. V. Netherlands 100 6 Ownership held as partnership interest.
MedImmune U. K. Limited England 100 7 Ownership held in preference, deferred and ordinary shares.
8 Ownership held in class A shares.
MedImmune Ventures, Inc. United States 100 9 Ownership held in class A voting preference shares, class A non-voting preference shares, 1 MedImmune, LLC United States 100 and class B voting preference shares.
10 Ownership held in class B ordinary shares and class C ordinary shares.
Meronem Group Limited England 100 11 Ownership held in class A voting and class A non-voting shares.
12 Ownership held in class B preference shares.
Novastra Promoo e Comrcio Farmacutico LdaPortugal 100 13 Ownership held in class C preference shares.
Novastuart Produtos Farmaceuticos Lda Portugal 100 14 Ownership held in class D preference shares.
15 Ownership held in class A preference shares and class B preference shares.
Omthera Pharmaceuticals Inc. United States 100 16 Ownership held in class D preference shares and class E preference shares.
17 Optein, Inc. United States 100 Ownership held in class A preference shares.
Pearl Therapeutics, Inc. United States 100 AstraZeneca Annual Report and Form 20-F Information 2015 195
